LEE BROCATO: Open Payments
NPI 1215365119 · FT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,169 in 111 payments from 34 companies in 2025. Trend: 2023 $1,008 · 2024 $2,753 · 2025 $2,169
Food & beverage: $2,070Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $222 |
| Daiichi Sankyo Inc. | 17 | $192 |
| Celgene Corporation | 8 | $181 |
| Incyte Corporation | 4 | $159 |
| Janssen Biotech, Inc. | 10 | $149 |
| Novartis Pharmaceuticals Corporation | 9 | $137 |
| GENZYME CORPORATION | 5 | $124 |
| Genmab U.S., Inc. | 3 | $83 |
| Geron Corporation | 3 | $68 |
| SERVIER PHARMACEUTICALS LLC | 3 | $59 |
Products named: Epkinly, REBLOZYL, Vanflyta, ERLEADA, IMBRUVICA, SARCLISA, BRUKINSA, RYTELO.
Industry payments across TX — which companies pay providers there.
